Moomoo AI 已提取核心信息
Sabby Volatility Warrant Master Fund, Ltd., Sabby Management, LLC, and Hal Mintz have filed an amended Schedule 13G/A with the United States Securities and Exchange Commission on January 2, 2024, indicating that they no longer beneficially own more than five percent of RedHill Biopharma Ltd.'s ADSs as of December 31, 2023. The filing shows that all three reporting persons have zero shares and zero percent ownership in the class of securities. The entities are associated with each other, with Sabby Management, LLC serving as the investment manager of Sabby Volatility Warrant Master Fund, Ltd., and Hal Mintz being the manager of Sabby Management, LLC. The filing includes a certification stating that the securities were not acquired for the purpose of changing or influencing the control of RedHill Biopharma and were not held in connection with any transaction having that purpose or effect.
Sabby Volatility Warrant Master Fund, Ltd., Sabby Management, LLC, and Hal Mintz have filed an amended Schedule 13G/A with the United States Securities and Exchange Commission on January 2, 2024, indicating that they no longer beneficially own more than five percent of RedHill Biopharma Ltd.'s ADSs as of December 31, 2023. The filing shows that all three reporting persons have zero shares and zero percent ownership in the class of securities. The entities are associated with each other, with Sabby Management, LLC serving as the investment manager of Sabby Volatility Warrant Master Fund, Ltd., and Hal Mintz being the manager of Sabby Management, LLC. The filing includes a certification stating that the securities were not acquired for the purpose of changing or influencing the control of RedHill Biopharma and were not held in connection with any transaction having that purpose or effect.
Sabby波动率权证万事达基金有限公司、Sabby Management, LLC和Hal Mintz已于2024年1月2日向美国证券交易委员会提交了经修订的附表13G/A，表明他们不再以实益方式拥有RedHill Biopharma Ltd.超过5％的股份。”s 截至2023年12月31日的ADS。该文件显示，所有三个申报人在该类别证券中的股份均为零，所有权为零。这些实体相互关联，Sabby Management, LLC担任Sabby波动率权证主基金有限公司的投资经理，哈尔·明兹是Sabby Management, LLC的经理。该文件包括一份证明，表明收购这些证券不是为了改变或影响RedHill Biopharma的控制权，也不是与任何具有该目的或效果的交易有关而持有的。
Sabby波动率权证万事达基金有限公司、Sabby Management, LLC和Hal Mintz已于2024年1月2日向美国证券交易委员会提交了经修订的附表13G/A，表明他们不再以实益方式拥有RedHill Biopharma Ltd.超过5％的股份。”s 截至2023年12月31日的ADS。该文件显示，所有三个申报人在该类别证券中的股份均为零，所有权为零。这些实体相互关联，Sabby Management, LLC担任Sabby波动率权证主基金有限公司的投资经理，哈尔·明兹是Sabby Management, LLC的经理。该文件包括一份证明，表明收购这些证券不是为了改变或影响RedHill Biopharma的控制权，也不是与任何具有该目的或效果的交易有关而持有的。
有用
没用